ZYME FY 2021 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M-31.5% YoY

Gross Profit

$27M100.0% margin

Operating Income

-$216M-808.2% margin

Net Income

-$212M-794.0% margin

EPS (Diluted)

$-4.61

Cash Flow

Operating Cash Flow

-$192M

Free Cash Flow

-$206M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$389M

Total Liabilities

$140M

Stockholders' Equity

$249M

Cash & Equivalents

$202M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$39M	-31.5%
Gross Profit	$27M	-$132M	+120.2%
Operating Income	-$216M	-$187M	-15.0%
Net Income	-$212M	-$181M	-17.3%